FDA Adverse Event Injury Summary report: N

AMPLATZER CRIBRIFORM OCCLUDER

MDR report key: 3761346 · Received April 21, 2014

Report

Report Number
2135147-2014-00034
Event Type
Injury
Date Received
April 21, 2014
Date of Event
April 5, 2014
Report Date
April 7, 2014
Manufacturer
AGA MEDICAL CORPORATION
Product Code
MLV
PMA / PMN Number
P000039/S013
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

SJM COULD NOT EVALUATE THE ACO INVOLVED IN THIS INCIDENT SINCE IT WAS NOT RETURNED TO US. THE DEVICE'S MANUFACTURING RECORDS COULD NOT BE REVIEWED SINCE THE LOT NUMBER FOR THE AFFECTED PRODUCT WAS NOT PROVIDED TO ST. JUDE MEDICAL. HOWEVER, EACH DEVICE IS INSPECTED BY CERTIFIED OPERATORS TO ENSURE EACH DEVICE IS ACCEPTABLE DURING MANUFACTURING AND PRIOR TO SHIPMENT.

Description of Event or Problem · 1

A 35MM AMPLATZER CRIBRIFORM OCCLUDER (ACO) WAS USED TO CLOSE A PATENT FORAMEN OVALE (PFO) FOR A PATIENT WITH PLATYPNEA ORTHODEOXIA DISORDER. AT SOME POINT POST PROCEDURE THE ACO SHIFTED ALLOWING THE PFO TO OPEN, RESULTING IN DESATURATION AND A PERSISTENT RIGHT TO LEFT SHUNT. THE PATIENT RETURNED TO THE CATH LAB WHERE PERCUTANEOUS RETRIEVAL WAS ATTEMPTED BUT THE SNARED ACO EMBOLIZED. THE PATIENT WAS SENT TO SURGERY TO HAVE THE ACO REMOVED AND THE DEFECT CLOSED WITH A PATCH.

Description of Event or Problem · 1

A 35MM AMPLATZER CRIBRIFORM OCCLUDER (ACO) WAS USED TO CLOSE A COMPLEX ATRIAL SEPTAL DEFECT FOR A PATIENT WITH PLATYPNEA ORTHODEOXIA DISORDER. THE PATIENT STILL HAD DESATURATION ISSUES AFTER DEVICE PLACEMENT. ECHO SHOWED THE ACO TO BE IN GOOD POSITION, BUT A RESIDUAL SHUNT REMAINED. THE PATIENT WAS SENT TO SURGERY TWO DAYS AFTER IMPLANT TO HAVE THE ACO REMOVED AND THE DEFECT CLOSED WITH A PATCH.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
239950 AMPLATZER CRIBRIFORM OCCLUDER CARDIAC OCCLUSION DEVICE MLV AGA MEDICAL CORPORATION 9-ASD-MF-035

Patients

Seq Age Sex Outcome Treatment
1 66 YR Required Intervention SNARE